MannKind | MNKD - Market Capitalization


MannKind reported $1.02B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.7B 757M Nov/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
Insmed USD 24.93B 1.82B Sep/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 151M 143M Nov/2026
MannKind USD 1.02B 237M Nov/2026
Merck USD 375.59B 17.09B Nov/2026
Novavax USD 1.09B 316M Dec/2025
Novo Nordisk DKK 212.17B 55.02B Jun/2026
Pfizer USD 169.88B 6.47B Nov/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Xencor USD 2.14B 281M Nov/2026